SMTI logo

SMTI
Sanara MedTech Inc

202
Mkt Cap
$210.77M
Volume
29,509.00
52W High
$35.95
52W Low
$16.05
PE Ratio
-5.91
SMTI Fundamentals
Price
$23.53
Prev Close
$23.00
Open
$23.00
50D MA
$18.99
Beta
1.41
Avg. Volume
39,994.04
EPS (Annual)
-$4.36
P/B
29.99
Rev/Employee
$954,796.13
$232.95
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara...
PR Newswire·7d ago
News Placeholder
More News
News Placeholder
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call
read more...
Benzinga·9d ago
News Placeholder
ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of +10.67% and +1.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
Insulet (PODD) delivered earnings and revenue surprises of +24.84% and +4.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Sanara MedTech (SMTI) Projected to Post Earnings on Tuesday
Sanara MedTech (NASDAQ:SMTI) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...
MarketBeat·16d ago
News Placeholder
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·17d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara...
PR Newswire·21d ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Coverage Initiated by Analysts at Lake Street Capital
Lake Street Capital began coverage on Sanara MedTech in a report on Wednesday. They issued a "buy" rating and a $32.00 price target for the company...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Lowers Earnings Estimates for Sanara MedTech
Sanara MedTech Inc. (NASDAQ:SMTI - Free Report) - Analysts at HC Wainwright cut their Q1 2026 earnings per share estimates for shares of Sanara MedTech in a research note issued on Thursday, April...
MarketBeat·1mo ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen cut Sanara MedTech from a "buy" rating to a "hold" rating in a research note on Sunday...
MarketBeat·2mo ago
<
1
2
...
>

Latest SMTI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.